ASX - By Stock
|
OPT |
Big volume in US today
|
|
PabloOD
|
22 |
8.4K |
4 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
22
|
8.4K
|
4
|
|
ASX - By Stock
|
OPT |
Thinking of OPT competitors
|
|
PabloOD
|
5 |
2.1K |
3 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
5
|
2.1K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Present at SVB Leerink Healthcare Conference
|
|
PabloOD
|
20 |
10K |
2 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
20
|
10K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Analyst Upgrade
|
|
PabloOD
|
88 |
47K |
1 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
88
|
47K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Analyst Upgrade
|
|
PabloOD
|
88 |
47K |
1 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
88
|
47K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Analyst Upgrade
|
|
PabloOD
|
88 |
47K |
1 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
88
|
47K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Analyst Upgrade
|
|
PabloOD
|
88 |
47K |
8 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
88
|
47K
|
8
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Ceasing to be a substantial holder
|
|
PabloOD
|
33 |
10K |
1 |
11/12/20 |
11/12/20 |
ASX - By Stock
|
33
|
10K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Analyst Upgrade
|
|
PabloOD
|
88 |
47K |
3 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
88
|
47K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Analyst Upgrade
|
|
PabloOD
|
88 |
47K |
1 |
27/11/20 |
27/11/20 |
ASX - By Stock
|
88
|
47K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Analyst Upgrade
|
|
PabloOD
|
88 |
47K |
2 |
27/11/20 |
27/11/20 |
ASX - By Stock
|
88
|
47K
|
2
|
|
ASX - By Stock
|
OPT |
Analyst Upgrade
|
|
PabloOD
|
88 |
47K |
6 |
14/11/20 |
14/11/20 |
ASX - By Stock
|
88
|
47K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Change in substantial holding
|
|
PabloOD
|
3 |
1.8K |
1 |
06/11/20 |
06/11/20 |
ASX - By Stock
|
3
|
1.8K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID-19 ARDS & GVHD Update, Quarterly Report & Appendix 4C
|
|
PabloOD
|
159 |
62K |
0 |
30/10/20 |
30/10/20 |
ASX - By Stock
|
159
|
62K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID-19 ARDS & GVHD Update, Quarterly Report & Appendix 4C
|
|
PabloOD
|
159 |
62K |
2 |
30/10/20 |
30/10/20 |
ASX - By Stock
|
159
|
62K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
explain the market cap
|
|
PabloOD
|
134 |
55K |
2 |
15/07/20 |
15/07/20 |
ASX - By Stock
|
134
|
55K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
explain the market cap
|
|
PabloOD
|
134 |
55K |
2 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
134
|
55K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
explain the market cap
|
|
PabloOD
|
134 |
55K |
0 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
134
|
55K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
PabloOD
|
124 |
52K |
1 |
12/06/20 |
12/06/20 |
ASX - By Stock
|
124
|
52K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
explain the market cap
|
|
PabloOD
|
134 |
55K |
2 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
134
|
55K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
PabloOD
|
124 |
52K |
0 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
124
|
52K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
PabloOD
|
124 |
52K |
1 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
124
|
52K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
PabloOD
|
124 |
52K |
1 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
124
|
52K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
PabloOD
|
124 |
52K |
2 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
124
|
52K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
PabloOD
|
124 |
52K |
1 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
124
|
52K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
PabloOD
|
124 |
52K |
2 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
124
|
52K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
PabloOD
|
124 |
52K |
1 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
124
|
52K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Trading Halt
|
|
PabloOD
|
17 |
9.6K |
1 |
09/06/20 |
09/06/20 |
ASX - By Stock
|
17
|
9.6K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
1 year Price target?
|
|
PabloOD
|
43 |
22K |
3 |
20/05/20 |
20/05/20 |
ASX - By Stock
|
43
|
22K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Change in substantial holding
|
|
PabloOD
|
10 |
4.7K |
0 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
10
|
4.7K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Heads up: OPT is about to skyrocket
|
|
PabloOD
|
46 |
24K |
1 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
46
|
24K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Heads up: OPT is about to skyrocket
|
|
PabloOD
|
46 |
24K |
2 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
46
|
24K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Industry Mag
|
|
PabloOD
|
27 |
9.9K |
2 |
21/04/20 |
21/04/20 |
ASX - By Stock
|
27
|
9.9K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Industry Mag
|
|
PabloOD
|
27 |
9.9K |
1 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
27
|
9.9K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Heads up: OPT is about to skyrocket
|
|
PabloOD
|
46 |
24K |
0 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
46
|
24K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Industry Mag
|
|
PabloOD
|
27 |
9.9K |
0 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
27
|
9.9K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Heads up: OPT is about to skyrocket
|
|
PabloOD
|
46 |
24K |
5 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
46
|
24K
|
5
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Completes Patient Dosing in Phase 2a DME Trial
|
|
PabloOD
|
22 |
8.8K |
4 |
30/03/20 |
30/03/20 |
ASX - By Stock
|
22
|
8.8K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Change in substantial holding
|
|
PabloOD
|
42 |
12K |
1 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
42
|
12K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Change in substantial holding
|
|
PabloOD
|
42 |
12K |
4 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
42
|
12K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Change in substantial holding
|
|
PabloOD
|
42 |
12K |
1 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
42
|
12K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Change in substantial holding
|
|
PabloOD
|
42 |
12K |
2 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
42
|
12K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Becoming a substantial holder
|
|
PabloOD
|
38 |
16K |
0 |
17/03/20 |
17/03/20 |
ASX - By Stock
|
38
|
16K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Becoming a substantial holder
|
|
PabloOD
|
38 |
16K |
2 |
16/03/20 |
16/03/20 |
ASX - By Stock
|
38
|
16K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Becoming a substantial holder
|
|
PabloOD
|
38 |
16K |
2 |
16/03/20 |
16/03/20 |
ASX - By Stock
|
38
|
16K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Becoming a substantial holder
|
|
PabloOD
|
38 |
16K |
0 |
12/03/20 |
12/03/20 |
ASX - By Stock
|
38
|
16K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Present at SVB Leerink Healthcare Conference
|
|
PabloOD
|
24 |
124K |
1 |
09/03/20 |
09/03/20 |
ASX - By Stock
|
24
|
124K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Present at SVB Leerink Healthcare Conference
|
|
PabloOD
|
24 |
124K |
0 |
09/03/20 |
09/03/20 |
ASX - By Stock
|
24
|
124K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Present at SVB Leerink Healthcare Conference
|
|
PabloOD
|
24 |
124K |
1 |
03/03/20 |
03/03/20 |
ASX - By Stock
|
24
|
124K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Present at SVB Leerink Healthcare Conference
|
|
PabloOD
|
24 |
124K |
2 |
02/03/20 |
02/03/20 |
ASX - By Stock
|
24
|
124K
|
2
|
|